QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
(Address of Principal Executive Offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
per share |
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer |
☐ | Emerging growth company | ||||
Smaller reporting company |
Item 1: |
Financial Statements |
July 2, 2023 |
December 31, 2022 |
|||||||
(in thousands, except per share amount) |
||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Marketable securities |
||||||||
Accounts receivable, less allowance for credit losses of $ |
||||||||
Inventories, net |
||||||||
Prepayments |
||||||||
Other current assets |
||||||||
Total current assets |
||||||||
Property, plant and equipment, net |
||||||||
Operating lease right-of-use |
||||||||
Marketable securities |
||||||||
Deferred tax assets |
||||||||
Retirement plans assets |
||||||||
Other assets |
||||||||
Acquired intangible assets, net |
||||||||
Goodwill |
||||||||
Total assets |
$ | $ | ||||||
LIABILITIES |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued employees’ compensation and withholdings |
||||||||
Deferred revenue and customer advances |
||||||||
Other accrued liabilities |
||||||||
Operating lease liabilities |
||||||||
Income taxes payable |
||||||||
Current debt |
||||||||
Total current liabilities |
||||||||
Retirement plans liabilities |
||||||||
Long-term deferred revenue and customer advances |
||||||||
Long-term other accrued liabilities |
||||||||
Deferred tax liabilities |
||||||||
Long-term operating lease liabilities |
||||||||
Long-term incomes taxes payable |
||||||||
Total liabilities |
||||||||
Commitments and contingencies (Note P) |
||||||||
SHAREHOLDERS’ EQUITY |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
Retained earnings |
||||||||
Total shareholders’ equity |
||||||||
Total liabilities and shareholders’ equity |
$ |
$ |
||||||
For the Three Months Ended |
For the Six Months Ended |
|||||||||||||||
July 2, 2023 |
July 3, 2022 |
July 2, 2023 |
July 3, 2022 |
|||||||||||||
(in thousands, except per share amount) |
||||||||||||||||
Revenues: |
||||||||||||||||
Products |
$ | $ | $ | $ | ||||||||||||
Services |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenues |
||||||||||||||||
Cost of revenues: |
||||||||||||||||
Cost of products |
||||||||||||||||
Cost of services |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
||||||||||||||||
Operating expenses: |
||||||||||||||||
Selling and administrative |
||||||||||||||||
Engineering and development |
||||||||||||||||
Acquired intangible assets amortization |
||||||||||||||||
Restructuring and other |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income from operations |
||||||||||||||||
Non-operating (income) expense: |
||||||||||||||||
Interest income |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Interest expense |
||||||||||||||||
Other (income) expense, net |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income before income taxes |
||||||||||||||||
Income tax provision |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income per common share: |
||||||||||||||||
Basic |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average common shares—basic |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average common shares—diluted |
||||||||||||||||
|
|
|
|
|
|
|
|
For the Three Months Ended |
For the Six Months Ended |
|||||||||||||||
July 2, 2023 |
July 3, 2022 |
July 2, 2023 |
July 3, 2022 |
|||||||||||||
(in thousands) |
||||||||||||||||
Net income |
$ | $ | $ | $ | ||||||||||||
Other comprehensive income, net of tax: |
||||||||||||||||
Foreign currency translation adjustment, net of tax of $ |
( |
) | ( |
) | ||||||||||||
Available-for-sale |
||||||||||||||||
Unrealized (losses) gains on marketable securities arising during period, net of tax of $( |
( |
) | ( |
) | ( |
) | ||||||||||
Less: Reclassification adjustment for losses included in net income, net of tax of $ $ |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
( |
) | ( |
) | ( |
) | |||||||||||
Cash flow hedges: |
||||||||||||||||
Unrealized gains arising during period, net of tax of $ |
||||||||||||||||
Less: Reclassification adjustment for losses included in net income, net of tax of $ |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Defined benefit post-retirement plan: |
||||||||||||||||
Amortization of prior service credit, net of tax of $ |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss) |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive income |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
Shareholders’ Equity |
||||||||||||||||||||||||||||
Convertible Common Shares Value |
Common Stock Shares |
Common Stock Par Value |
Additional Paid-in Capital |
Accumulated Other Comprehensive (Loss) Income |
Retained Earnings |
Total Shareholders’ Equity |
||||||||||||||||||||||
(in thousands) |
||||||||||||||||||||||||||||
For the Three Months Ended July 2, 2023 |
||||||||||||||||||||||||||||
Balance, April 2, 2023 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
Net issuance of common stock under stock-based plans |
||||||||||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||
Repurchase of common stock |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||
Cash dividends ($0.11 per share) |
( |
) |
( |
) | ||||||||||||||||||||||||
Settlements of convertible notes |
( |
) |
||||||||||||||||||||||||||
Exercise of convertible notes hedge call options |
( |
) |
( |
) |
||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||
Other comprehensive income |
||||||||||||||||||||||||||||
Balance, July 2, 2023 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
For the Three Months Ended July 3, 2022 |
||||||||||||||||||||||||||||
Balance, April 3, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
Net issuance of common stock under stock-based plans |
( |
) |
( |
) | ||||||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||
Repurchase of common stock |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||
Cash dividends ($0.11 per share) |
( |
) |
( |
) | ||||||||||||||||||||||||
Settlements of convertible notes |
( |
) |
( |
) | ||||||||||||||||||||||||
Exercise of convertible notes hedge call options |
( |
) |
( |
) |
||||||||||||||||||||||||
Cumulative-effect of change in accounting principle related to convertible debt |
||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||
Other comprehensive loss |
( |
) |
( |
) | ||||||||||||||||||||||||
Balance, July 3, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
For the Six Months Ended July 2, 2023 |
||||||||||||||||||||||||||||
Balance, December 31, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
Net issuance of common stock under stock-based plans |
( |
) |
( |
) | ||||||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||
Repurchase of common stock |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||
Cash dividends ($0.22 per share) |
( |
) |
( |
) | ||||||||||||||||||||||||
Settlements of convertible notes |
( |
) |
||||||||||||||||||||||||||
Exercise of convertible notes hedge call options |
( |
) |
( |
) |
||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||
Other comprehensive income |
||||||||||||||||||||||||||||
Balance, July 2, 2023 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
For the Six Months Ended July 3, 2022 |
||||||||||||||||||||||||||||
Balance, December 31, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
Net issuance of common stock under stock-based plans |
( |
) |
( |
) | ||||||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||
Repurchase of common stock |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||
Cash dividends ($0.22 per share) |
( |
) |
( |
) | ||||||||||||||||||||||||
Settlements of convertible notes |
( |
) |
( |
) | ||||||||||||||||||||||||
Exercise of convertible notes hedge call options |
( |
) |
( |
) |
||||||||||||||||||||||||
Cumulative-effect of change in accounting principle related to convertible debt |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||
Other comprehensive loss |
( |
) |
( |
) | ||||||||||||||||||||||||
Balance, July 3, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
For the Six Months Ended |
||||||||
July 2, 2023 |
July 3, 2022 |
|||||||
(in thousands) |
||||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | $ | ||||||
Adjustments to reconcile net income from operations to net cash provided by operating activities: |
||||||||
Depreciation |
||||||||
Stock-based compensation |
||||||||
Provision for excess and obsolete inventory |
||||||||
Amortization |
||||||||
Deferred taxes |
( |
) | ( |
) | ||||
(Gains) losses on investments |
( |
) | ||||||
Other |
( |
) | ||||||
Changes in operating assets and liabilities |
||||||||
Accounts receivable |
( |
) | ( |
) | ||||
Inventories |
( |
) | ( |
) | ||||
Prepayments and other assets |
( |
) | ( |
) | ||||
Accounts payable and other liabilities |
( |
) | ( |
) | ||||
Deferred revenue and customer advances |
( |
) | ||||||
Retirement plans contributions |
( |
) | ( |
) | ||||
Income taxes |
( |
) | ||||||
|
|
|
|
|||||
Net cash provided by operating activities |
||||||||
|
|
|
|
|||||
Cash flows from investing activities: |
||||||||
Purchases of property, plant and equipment |
( |
) | ( |
) | ||||
Purchases of marketable securities |
( |
) | ( |
) | ||||
Proceeds from sales of marketable securities |
||||||||
Proceeds from maturities of marketable securities |
||||||||
Proceeds from life insurance |
||||||||
|
|
|
|
|||||
Net cash used for investing activities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Cash flows from financing activities: |
||||||||
Repurchase of common stock |
( |
) | ( |
) | ||||
Dividend payments |
( |
) | ( |
) | ||||
Payments related to net settlement of employee stock compensation awards |
( |
) | ( |
) | ||||
Payments of convertible debt principal |
( |
) | ( |
) | ||||
Issuance of common stock under stock purchase and stock option plans |
||||||||
|
|
|
|
|||||
Net cash used for financing activities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Effects of exchange rate changes on cash and cash equivalents |
||||||||
|
|
|
|
|||||
Decrease in cash and cash equivalents |
( |
) | ( |
) | ||||
Cash and cash equivalents at beginning of period |
||||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | $ | ||||||
|
|
|
|
|||||
Non-cash investing activities: |
||||||||
Capital expenditures incurred but not yet paid: |
$ | $ |
• | semiconductor test (“Semiconductor Test”) systems; |
• | storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”); |
• | wireless test (“Wireless Test”) systems; and |
• | robotics (“Robotics”) products. |